凝血因子异常与连续流左心室辅助装置患者抗Xa因子与活化部分凝血活酶时间不一致相关
本研究纳入连续流左心室辅助装置(CF-LVAD)患者,同步检测抗Xa因子、aPTT及凝血因子II、V、VII、VIII、IX、X、XI、XII。总体抗Xa因子与aPTT不一致率为74.7%(568/760样本,62例患者)。结论提示除华法林影响外,低因子XII或V等可能 contribute 不一致,凝血因子水平或有助于个体化抗凝目标。
要点
- CF-LVAD患者抗Xa因子与aPTT不一致率高达74.7%。
- INR≤1.0时不一致率31.8%,INR>1.8时达82.7%。
- 低因子XII者90.9%存在不一致,低因子V者全部不一致。
核心结论
- 除华法林对aPTT的影响外,低因子XII或V等也可能导致aPTT与抗Xa因子不一致。
- 凝血因子水平可能帮助CF-LVAD患者静脉普通肝素抗凝目标的个体化。
研究设计与样本
- 连续纳入因静脉普通肝素治疗住院的CF-LVAD患者,同步检测抗Xa因子、INR、aPTT、乳酸脱氢酶及凝血因子II、V、VII、VIII、IX、X、XI、XII。
主要发现
- 总体抗Xa因子与aPTT不一致率为74.7%(568/760样本,来自62例患者)。
- 同步检测凝血因子的样本中不一致率为66%(49/74样本,来自52例患者)。
- INR≤1.0时不一致率为31.8%,INR>1.8时为82.7%。
- 低维生素K依赖因子与正常者不一致率无差异(65.9% vs 64.7%,p=0.99)。
- 低因子XII占15%,其中90.9%不一致;低因子V占8.2%,全部不一致;因子VIII升高占97%,其中65.7%不一致。
临床怎么用
- CF-LVAD患者静脉普通肝素抗凝时,若aPTT与抗Xa因子不一致,可考虑检测凝血因子XII、V、VIII等协助解释。
- 凝血因子水平可能用于个体化设定抗凝目标,但需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High levels of discordance between activated partial thromboplastin time (aPTT) and anti-factor Xa (anti-FXa) have been reported in patients with continuous-flow left ventricular assist devices (CF-LVADs). We sought to determine the biochemical basis for discordance by simultaneous measurement of coagulation factors with aPTT and anti-FXa. METHODS: Consecutive CF-LVAD patients admitted for intravenous unfractionated heparin (IV-UFH) therapy were studied. IV-UFH was monitored based on an anti-FXa. International normalized ratio (INR), aPTT, lactate dehydrogenase, and coagulation factors II, V, VII, VIII, IX, X, XI, and XII were measured simultaneously with anti-FXa. RESULTS: The discordance rate between anti-FXa and aPTT was 74.7% overall (568 of 760 samples from 62 patients). In samples in which coagulation factors were simultaneously measured, the discordance rate was 66% (49 of 74 samples from 52 patients). In patients with INR ≤ 1.0 the discordance level was 31.8% vs 82.7% with INR > 1.8. No difference was observed in the rate of discordance between samples with low vs normal vitamin K-dependent factors (65.9% vs 64.7%, p = 0.99). Low factor XII was found in 15%; of these, 90.9% exhibited anti-FXa/aPTT discordance. Low factor V was found in 8.2%, and all were discordant. Factor VIII was elevated in 97% of samples, and 65.7% were discordant. CONCLUSIONS: In addition to the effects of warfarin administration on aPTT, the influence of other factors, such as low factor XII or V, may contribute to the discordance between aPTT values and anti-FXa. Coagulation factor levels may assist in individualization of anti-coagulation targets while patients implanted with CF-LVADs are on IV-UFH.
引用
- Adatya S, Sunny R, Fitzpatrick MJ, et al. Coagulation factor abnormalities related to discordance between anti-factor Xa and activated partial thromboplastin time in patients supported with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2016. PMID: 27836023. doi:10.1016/j.healun.2016.09.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。